Mesothelioma Cure

Is Mesothelioma Curable?

There isn’t a definitive cure for mesothelioma. However, data shows a 1-year survival rate of 79.6% for pleural mesothelioma patients who receive multimodal care, and 50% of peritoneal patients who receive HIPEC survive 5 years or more. According to our 2025 patient survey, 11% of respondents achieved remission, 100% of whom underwent active treatment. Overall, 12% of all mesothelioma patients who receive treatment survive 5 years or more.

Mesothelioma Remission: Our 2025 Patient Survey Results

• Chemotherapy success: Carboplatin was associated with a 72% higher remission rate for those undergoing chemotherapy.
• Expert consultation: 95% of people in remission consulted 2 or more doctors.
• Remission rate: 11% of survey respondents reported their treatment led to remission.
• Surgical outcomes: 23% of patients who achieved remission had surgery as part of their care plan.
• Treatment protocol: 100% of patients in remission underwent some form of active mesothelioma treatment.

While experts continue to pursue a complete cure, mesothelioma can often be managed as a chronic condition. Because this cancer spreads quickly and symptoms often don’t appear for many years, most cases are diagnosed at a later stage. At that point, the goal of treatment shifts from a definitive cure to achieving partial remission, which is when the cancer shrinks or stops growing.

As our 2025 survey data shows, the path to remission almost always involves a combination of specialized therapies and multiple medical opinions. Even if a patient has already spoken to two doctors, seeking further expertise can be the turning point in finding a successful mesothelioma treatment path. This was the case for 95% of our successful survey respondents.

Expert Insight

“I try to encourage patients to think of it more in terms of a goal of long-term survival with good quality survival,” mesothelioma specialist Dr. Andrea Wolf tells us. Seeing a mesothelioma specialist can also lead to better results.

Dr. Andrea Wolf , thoracic surgeon and mesothelioma researcher

Mesothelioma Remission

Mesothelioma remission means your cancer has responded well to treatment. Doctors generally look for 2 types of remission: partial and complete. While complete remission is the goal, both types are major treatment victories that allow people to manage the disease and enjoy more time with their families.

Determining Mesothelioma Remission

• Achieving remission: This usually involves tumors shrinking and mesothelioma symptoms improving for at least 1 month. 
• Complete remission: Means doctors can’t detect any signs of cancer on your scans.
• Partial remission: Occurs when tumors shrink 50% or more. 

Remission is a separate concept from overall survival. Survival rates measure how long a person lives with the disease, while remission describes a period where the cancer is specifically shrinking or undetectable. For example, many peritoneal mesothelioma patients who have surgery with HIPEC reach higher 5-year survival rates. However, the specific goal for these patients remains reaching a state of remission to improve their daily health and comfort.

Living a Full Life With Mesothelioma

A definitive cure is the ultimate goal of researchers, but many mesothelioma survivors have already found ways to live active and fulfilling lives. Success often comes when patients manage the cancer as a chronic condition, which allows them to maintain a sense of normalcy and continue their daily routines. This approach combines advanced medical care with a strong focus on personal well-being.

Tips for Living Well During Mesothelioma Treatment

• Build a support network: Lean on family, friends, and survivor communities to manage the emotional challenges of a diagnosis. Support groups offer a safe place to share stories with people who truly understand your experience.
• Focus on physical health: Keep your strength up through gentle exercise like walking or light stretching. Proper nutrition and enough rest help the body handle treatment side effects more effectively.
• Prioritize mental well-being: Look toward the future through small goals and stay informed about new therapies like immunotherapy. A positive outlook and mental health support can significantly improve your overall quality of life.

Quality of life care is a vital part of this process. Managing symptoms and controlling pain help you feel your best while you undergo therapy. Counseling and support groups also help reduce the feeling of isolation that often comes with a cancer journey.

Some patients reach incredible milestones. Trina Reif has lived with peritoneal mesothelioma for more than 20 years. Kim Madril is thriving long after her pleural mesothelioma treatment, and Carla Fasolo remains an active advocate for others with the disease. These stories show that long-term survival is possible for patients who receive comprehensive, multimodal care at experienced cancer centers.

Survivor Experience

“You’re almost grateful for what you have. I’m grateful that I am still here. I am so happy that I’m still here. Embrace the moment,” she tells us. “I’m at the point in my life where things that might have bothered me before don’t. I think, ‘Oh, well. That’s certainly not as bad as going through radiation. It’s certainly not as bad as having surgery.”

Kim Madril , pleural mesothelioma survivor

Verified Asbestos.com Survivor

Latest Research for a Mesothelioma Cure

Researchers are closer than ever to finding a cure for mesothelioma. Recent FDA approvals and new immunotherapy combinations show medical science is advancing toward more effective, long-term solutions. Global studies now focus on harnessing the immune system, using genetics to personalize therapy and blocking the signals that tell cancer cells to grow.

One promising study involves proteins like MCP-1. New research from 2025 in the journal Cancer Biomarkers suggests targeting this protein could lead to better ways to treat fluid buildup around the lungs. These innovations help doctors move beyond traditional methods to fight the disease more precisely.

Recent Mesothelioma Treatment Breakthroughs

• Opdivo and Yervoy immunotherapy: This combination became a standard treatment after its 2020 FDA approval. It proved that immunotherapy can successfully treat mesothelioma and changed how doctors approach this cancer.
• Keytruda and chemo combination: This first-line treatment for advanced pleural mesothelioma set a new standard of care in 2024. The KEYNOTE-483 trial confirmed this approach significantly extends overall survival.
• Pre-surgery immunotherapy: Johns Hopkins experts recently tested a sequence of Opdivo and Yervoy before surgery, then administered more immunotherapy afterward. Results from this 2025 Phase 2 trial showed patients lived a median of 28.6 months, which is much higher than the typical 18 month average.

Results from the Johns Hopkins trial show that 36% of patients remained cancer-free at their follow-up. This data proves that using immunotherapy before surgery is a safe and effective option for improving patient outcomes.

Gene therapy and CRISPR editing specifically attack mesothelioma at the genetic level to stop tumor growth. Researchers are even developing drugs like Avastin to starve tumors, cutting off their blood supply. These tools mean that even if a doctor can’t offer a traditional mesothelioma cure today, the options for effective treatment are growing every year.

Immunotherapy marked a turning point when the FDA approved Opdivo (nivolumab) and Yervoy (ipilimumab) in 2020. In September 2024, the agency approved Keytruda (pembrolizumab) with chemo as the first-line treatment for pleural mesothelioma, a major step toward longer survival and improved quality of life.

Gene therapy and CRISPR gene editing show promise by targeting cancer growth at the genetic level. Viral-based gene therapies use modified viruses to deliver tumor-suppressing genes. Researchers are also developing next-generation angiogenesis inhibitors like Avastin (bevacizumab), which starves tumors by cutting off the blood supply.

Other emerging treatments include epigenetic therapy, which explores how chemical changes in DNA can turn off anticancer mechanisms. Photodynamic therapy activates drugs with light to kill cancer cells without harming healthy tissue.

500+ SPECIALISTS AVAILABLE

Get to the Right Doctor, Faster

Connect with top-rated doctors specializing in mesothelioma treatment, who will personalize treatment options based on your diagnosis.

Find Your Doctor

Breakthroughs in Clinical Trials

Clinical trials in 2026 continue to increase the number of effective options for treating mesothelioma. Now that trials like KEYNOTE-483 have set new care standards, researchers are testing more advanced and diverse treatment combinations. For example, Baylor College of Medicine and Duke University are conducting the NEMO trial. This study tests immunotherapy combined with chemo both before and after surgery to improve outcomes for eligible patients.

Enrolling in these trials gives you a path to the latest new and emerging mesothelioma treatments before they’re available to the general public. These programs allow you to access advanced surgical techniques and precision monitoring that help extend survival. These breakthroughs show that while there isn’t a single cure yet, the list of effective treatment options grows every year.

Mesothelioma Research Centers

Much of the most impactful research happens at specialized treatment centers across the United States. These facilities range from laboratory-focused programs to those managing large-scale clinical trials. The National Cancer Institute is one of several organizations that fund these programs to help improve mesothelioma treatment and survival rates.

Centers Conducting Mesothelioma Research

• AdventHealth Celebration in Kissimmee, Florida
• Harvard Medical School and Brigham and Women’s Hospital
• Mount Sinai Hospital in New York City
• National Institutes of Health
• Shukla Research Lab at the University of Vermont
• Vaccine and Immunotherapy Center at Massachusetts General Hospital

Top treatment centers offer the best resources for treating complex mesothelioma cases. Specialists at these locations work in multidisciplinary teams to ensure you receive the most comprehensive care possible. Our Patient Advocates can help you find a mesothelioma specialist and learn more about which active trials may be right for you.

Exclusive Content

Dr. Jacques Fontaine: The Future of Mesothelioma Treatment

View Transcript

What is the future hold for mesothelioma treatment? I think the future for mesothelioma treatment is a bright one. I’ll tell you a story. When I was at an intern, in Montreal, I remember seeing my first mesothelioma patient. This is in the early nineties.

And when I spoke to the professor and explained to them, the case of mesothelioma, the professor told me you know the best type of treatment for this patient is to give him a fishing pole and tell him to go fishing.

Then years later, I went to Bringham and Women’s Hospital with Dr. Sugar Baker, and then learned that there’s a lot of options for mesothelioma. And as the science continues to grow, as we start looking at it from a different angle, as we start thinking outside the box, There’s gonna be a lot of innovative and very interesting treatments for this disease.

I think the way to make a progress is to think outside the box, learn how to make the patient’s immune system go after these cancer cells.

Learn how to find a better way to diagnose and diagnose this disease earlier and find ways to use the patient’s genes to beat this disease. And that’s what I and my team at Moffitt Cancer Center try to achieve for our patients. Innovative ways with our clinical trials, cutting edge radiation therapy that we offer, and state of the art surgery for our mesothelioma patients.

Current Mesothelioma Treatments and How They’re Changing

A big part of finding a cure is making existing mesothelioma treatments work better. Surgeries become more precise, chemo and radiation work more effectively and the timing of these therapies and combinations is refined.

When the FDA approved Opdivo (nivolumab) and Yervoy (ipilimumab), immunotherapy became a standard treatment for mesothelioma. Experts continue to find ways to refine these therapies studying new combinations with chemo, radiation and surgery.

Advancements in Mesothelioma Treatment

• Chemotherapy: The FDA approved a combination of Alimta (pemetrexed) and platinum chemo with the immunotherapy drug Keytruda (pembrolizumab) as a first-line treatment for advanced pleural mesothelioma in September 2024. Current research focuses on how these combinations improve overall survival for patients with advanced stages of the disease.
• Immunotherapy: This standard treatment is currently FDA-approved specifically for pleural mesothelioma, though research is underway to expand its use to other types. One clinical trial currently recruiting will compare chemo alone to chemo with immunotherapy for peritoneal mesothelioma.
• Multimodal therapy: Doctors use combinations of different therapies, such as surgery and chemo, to create a more effective treatment plan. Clinical trials are now looking at the timing of these therapies, such as adding immunotherapy before a surgical procedure.
• Radiation: This traditional therapy uses high-energy beams to shrink tumors and is being explored in several new applications. Researchers are now looking at the benefits of using radiation before surgery or combining it with immunotherapy drugs.
• Surgery: Specialists continually refine surgical techniques to make them less invasive and more effective at removing visible tumor mass. Clinical trials also look at new pairings, such as a recent pilot study that tested surgery with photodynamic therapy.
• Tumor Treating Fields: This FDA-approved therapy uses low-intensity electrical fields to disrupt the division of mesothelioma cancer cells. When used with chemo, TTFields have been shown to extend survival about 4 to 6 months for patients with unresectable pleural mesothelioma.

Ongoing refinements in these treatments are steadily improving how doctors treat mesothelioma. These advances enhance the effectiveness of treatments and offer patients better chances to live longer with improved quality of life. As research continues, combining and sequencing therapies more precisely remains key to making progress toward a future cure.